[Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].
Personal experience with the use of betamethasone, used orally in associated with various cytostatic drugs for inducing remission in acute lymphatic leucosis and some cases of lymphoproliferative disease is reported. The results obtained point to the effectiveness and tolerance of the drug, even in the high doses that are required to treat such blood diseases.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000627:therapeutic use*; D001803:Blood Transfusion; D002648:Child; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001623:Betamethasone
Il betametasone nel trattamento della leucosi linfatica acuta e di altre malattie linfoproliferative.